Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00710996 · ClinicalTrials.gov registry record
Blue Light Intraocular Lenses (IOLs) and Photostress
A clinical trial, sponsored by Alcon Research.
- Completed
- Registry status
- 58
- Enrollment target
NCT00710996: Completed study, sponsored by Alcon Research.
NCT00710996 is a clinical trial that has completed, run by Alcon Research. The registered enrollment target is 58 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00710996 has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- 58 participants
- Enrollment target
Study Summary
To determine what effect a blue light filtering Intraocular Lens (IOL) has on macular pigment levels.
Primary Outcome
The time necessary to recover function (e.g., contrast discrimination) following exposure to a bright glare source.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2008-01 |
| Est. Completion | 2008-10 |
What the finished NCT00710996 record still lists
NCT00710996 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 58 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00710996 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00710996 about?
NCT00710996 is a clinical study titled "Blue Light Intraocular Lenses (IOLs) and Photostress". To determine what effect a blue light filtering Intraocular Lens (IOL) has on macular pigment levels.
What is the current status of trial NCT00710996?
This trial is currently completed. The enrollment target is 58 participants. The study started on 2008-01. Estimated completion is 2008-10.
Who is sponsoring clinical trial NCT00710996?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03587844 · 58 participants · Phase 2
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
- NCT03630991 · 58 participants · Phase 1
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- NCT03949855 · 58 participants · Phase 2
Belimumab With Rituximab for Primary Membranous Nephropathy
- NCT04069273 · 58 participants · Phase 2
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia